XML 59 R38.htm IDEA: XBRL DOCUMENT v3.24.3
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2024202320242023
Net Income for Earnings Per Share Calculations:
Income from continuing operations, net of tax$362.1 $334.9 $1,051.0 $886.9 
Net loss attributable to noncontrolling interests(1.4)(1.2)(3.6)(2.8)
Income from continuing operations attributable to Edwards Lifesciences Corporation363.5 336.1 1,054.6 889.7 
Income from discontinued operations2,707.3 48.8 2,734.4 142.8 
Net income attributable to Edwards Lifesciences Corporation$3,070.8 $384.9 $3,789.0 $1,032.5 
Weighted Average Shares:
Basic weighted-average shares outstanding597.2 607.0 600.3 607.2 
Dilutive effect of stock plans0.9 2.5 1.9 3.0 
Dilutive weighted-average shares outstanding598.1 609.5 602.2 610.2 
Earnings per Share:
Basic:
Continuing operations$0.61 $0.55 $1.76 $1.47 
Discontinued operations4.53 0.08 4.55 0.23 
Basic earnings per share$5.14 $0.63 $6.31 $1.70 
Diluted:
Continuing operations$0.61 $0.55 $1.75 $1.46 
Discontinued operations4.52 0.08 4.54 0.23 
Diluted earnings per share$5.13 $0.63 $6.29 $1.69